Oliver Sartor Talks with Thomas A. Hope, Jeremie Calais, and Wolfgang P. Fendler About FDA Approval of PSMA.

Abstract

On December 1, the U.S. Food and Drug Administration (FDA) approved 68Ga-PSMA-11 for PET imaging of prostate-specific membrane antigen (PSMA)–positive lesions in men with prostate cancer. It is the first approval for a PSMA PET tracer in the United States. The approval was granted to the